PMID- 21086945
OWN - NLM
STAT- MEDLINE
DCOM- 20110104
LR  - 20160923
IS  - 1784-3227 (Print)
IS  - 1784-3227 (Linking)
VI  - 73
IP  - 3
DP  - 2010 Jul-Sep
TI  - Seroconversion of acute hepatitis B by antiretroviral therapy in an HIV-1 
      infected patient.
PG  - 389-91
AB  - A 33-year-old man with human immunodeficiency virus type1 (HIV-1) infection was 
      admitted because of acute hepatitis B. His serum alanine aminotransferase level 
      was 1200 IU/mL and CD4 cells count was 268/mm3. Antiretroviral therapy including 
      tenofovir and emtricitabine, which suppresses both HIV and hepatitis B virus 
      (HBV) replication, was initiated. The liver enzymes decreased dramatically. The 
      viral loads of both HIV-1 and HBV were suppressed below detectable limits. 
      Seroconversion from hepatitis B surface antigen to hepatitis B surface antibody 
      was acquired 19 weeks later. In this case, the initiation of antiretroviral 
      therapy with anti-HBV activity during the acute phase of hepatitis B had a 
      favourable effect on HBV serostatus.
FAU - Ikeda-Kamimura, Mahoko
AU  - Ikeda-Kamimura M
AD  - Division of Respiratory Medicine, National Hospital Organization, Higashi-Saitama 
      Hospital, Japan.
FAU - Horiba, Masahide
AU  - Horiba M
LA  - eng
PT  - Case Reports
PT  - Journal Article
PL  - Belgium
TA  - Acta Gastroenterol Belg
JT  - Acta gastro-enterologica Belgica
JID - 0414075
RN  - 0 (Hepatitis B e Antigens)
SB  - IM
MH  - Adult
MH  - Comorbidity
MH  - HIV Infections/*epidemiology
MH  - *HIV-1
MH  - Hepatitis B/*drug therapy/*epidemiology/immunology
MH  - Hepatitis B e Antigens/immunology
MH  - Humans
MH  - Male
MH  - Viral Load
EDAT- 2010/11/20 06:00
MHDA- 2011/01/05 06:00
CRDT- 2010/11/20 06:00
PHST- 2010/11/20 06:00 [entrez]
PHST- 2010/11/20 06:00 [pubmed]
PHST- 2011/01/05 06:00 [medline]
PST - ppublish
SO  - Acta Gastroenterol Belg. 2010 Jul-Sep;73(3):389-91.